1,7-phenanthroline has been researched along with Adenocarcinoma, Basal Cell in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Cerqueira, IH; Costa, AR; de Araujo-Neto, JH; De Grandis, RA; Demidoff, FC; Guedes, APM; Marques, WG; Moraes, CAF; Netto, CD; Pavan, FR; Resende, FA; Sampaio, NZ | 1 |
| Bodman-Smith, K; Daher, CF; Khnayzer, RS; Mansour, N | 1 |
| Chen, M; Liu, J; Wang, S; Wang, Y; Wu, Y; Zhang, W; Zhao, X | 1 |
| Chen, J; Chen, R; Ding, W; Feng, Y; Lu, Q; Ma, T; Xie, J; Yu, H; Zhu, T | 1 |
| Oberley, LW; Spitz, DR | 1 |
| Bazou, D; Medina, C; Radomski, MW; Santos-Martinez, MJ | 1 |
| Chen, L; Chen, T; He, QY; Liu, J; Liu, Y; Yang, X; Yang, Y; Zheng, W | 1 |
| Liu, J; Mao, JW; Mei, WJ; Sun, DD; Wang, WZ | 1 |
| Bastow, KF; Chen, CY; Lai, CY; Lee, KH; Ohkoshi, E; Pan, SL; Shi, Q; Teng, CM; Wang, CY; Wu, TS; Yang, PC; Yang, SC; Yang, X | 1 |
| Baba, M; Iishi, H; Mikuni, T; Narahara, H; Tatsuta, M; Uedo, N; Yano, H | 1 |
| Borlak, J; Halter, R; Rütters, H; Zürbig, P | 1 |
| Berger, W; Chiba, P; Dornetshuber, R; Elbling, L; Heffeter, P; Jakupec, MA; Keppler, BK; Körner, W; Micksche, M; Pirker, C; Sutterlüty, H | 1 |
| Caron, D; Doillon, CJ; Faure, RL; Lussier, JG; Olivier, M; Savard, PE; Shink, E | 1 |
| Darzi, AW; Jones, TL; Paraskeva, PA; Peck, DH; Ridgway, PF; Smith, A; Ziprin, P | 1 |
| Hiwada, K; Kokubu, T | 1 |
| Abrams, MJ; Bradley, FC; Caruso, FS; Douple, EB; Giandomenico, CM; McElligott, MA; O'Hara, JA | 1 |
16 other study(ies) available for 1,7-phenanthroline and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Male; Phenanthrolines; Reactive Oxygen Species; Ruthenium | 2022 |
A photoactivatable Ru (II) complex bearing 2,9-diphenyl-1,10-phenanthroline: A potent chemotherapeutic drug inducing apoptosis in triple negative human breast adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Phenanthrolines; Photochemical Processes; Ruthenium; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2021 |
Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Proliferation; G-Quadruplexes; Humans; Lung; Lung Neoplasms; Phenanthrolines; Pyrazoles; Telomere | 2017 |
Antitumor effect of a copper (II) complex of a coumarin derivative and phenanthroline on lung adenocarcinoma cells and the mechanism of action.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; Coordination Complexes; Coumarins; Female; Humans; Lung Neoplasms; Mice, Nude; Phenanthrolines; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Measurement of MnSOD and CuZnSOD activity in mammalian tissue homogenates.
Topics: Adenocarcinoma; Animals; Copper; Mammals; Mammary Glands, Animal; Manganese; Mitochondria, Liver; Nitroblue Tetrazolium; Phenanthrolines; Rats; Spectrophotometry; Superoxide Dismutase; Xanthine Oxidase; Zinc | 2001 |
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Topics: Actins; Adenocarcinoma; Apyrase; Blood Platelets; Cell Communication; Cell Line, Tumor; Down-Regulation; Edetic Acid; Epoprostenol; Female; Fibrosarcoma; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Microscopy, Confocal; Microscopy, Fluorescence; Ovarian Neoplasms; P-Selectin; Phenanthrolines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tumor Cells, Cultured; Ultrasonics; Ultrasonography | 2011 |
Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Coordination Complexes; Gene Expression; Humans; Imidazoles; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Phenanthrolines; Proto-Oncogene Proteins c-bcl-2; Ruthenium; Signal Transduction | 2012 |
Imidazo [4,5f][1,10] phenanthroline derivatives as inhibitor of c-myc gene expression in A549 cells via NF-κB pathway.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Inhibitory Concentration 50; Lung Neoplasms; Models, Chemical; Necrosis; NF-kappa B; Phenanthrolines; Proto-Oncogene Proteins c-myc; Tetrazolium Salts; Thiazoles | 2012 |
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
Topics: Adenocarcinoma; Alkaloids; Antineoplastic Agents; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Indoles; Lung Neoplasms; Phenanthrolines; Quinolizidines; Stereoisomerism; Structure-Activity Relationship | 2012 |
Suppression by iron chelator phenanthroline of sodium chloride-enhanced gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Apoptosis; Cell Division; Cocarcinogenesis; Drug Synergism; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Iron Chelating Agents; Lipid Peroxidation; Male; Methylnitronitrosoguanidine; Oxidation-Reduction; Phenanthrolines; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Sodium Chloride, Dietary; Stomach Neoplasms | 2003 |
Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice.
Topics: Adenocarcinoma; Animals; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Humans; Intercellular Signaling Peptides and Proteins; Lung; Lung Neoplasms; Mice; Mice, Transgenic; Neoplasm Metastasis; Organometallic Compounds; Peptides; Phenanthrolines; Promoter Regions, Genetic; Proteome; Proto-Oncogene Proteins c-raf; Pulmonary Surfactant-Associated Protein C; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2006 |
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Formazans; HL-60 Cells; Humans; Lanthanum; Lung Neoplasms; Molecular Structure; Neoplasm Proteins; Organic Anion Transporters; Organometallic Compounds; Phenanthrolines; Sensitivity and Specificity; Tetrazolium Salts | 2007 |
Protein tyrosine phosphatase inhibition induces anti-tumor activity: evidence of Cdk2/p27 kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells.
Topics: Adenocarcinoma; Calcium-Binding Proteins; Cell Culture Techniques; Cyclin-Dependent Kinase 2; Female; Humans; Organometallic Compounds; Ovarian Neoplasms; Phenanthrolines; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Tumor Cells, Cultured | 2008 |
Pneumoperitoneum augmented tumor invasiveness is abolished by matrix metalloproteinase blockade.
Topics: Adenocarcinoma; Carbon Dioxide; Cell Line, Transformed; Colonic Neoplasms; Humans; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neoplasm Seeding; Phenanthrolines; Pneumoperitoneum, Artificial; Protease Inhibitors; Time Factors; Tumor Cells, Cultured | 2002 |
Comparison of soluble and membrane-bound neutral arylamidases from renal cell carcinoma.
Topics: Adenocarcinoma; Aminopeptidases; Cell Membrane; Cobalt; Cytosol; Humans; Hydrogen-Ion Concentration; Kidney Neoplasms; Kinetics; Molecular Weight; Phenanthrolines | 1977 |
Combined modality treatment with ternary Cu(II) complexes and X rays.
Topics: 2,2'-Dipyridyl; Adenocarcinoma; Animals; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; Cricetulus; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organometallic Compounds; Phenanthrolines; Radiation-Sensitizing Agents | 1992 |